Maria Beumont
TB Alliance(US)
Publications by Year
Research Areas
Hepatitis C virus research, HIV/AIDS drug development and treatment, Hepatitis B Virus Studies, Liver Disease Diagnosis and Treatment, Systemic Lupus Erythematosus Research
Most-Cited Works
- → Telaprevir for Retreatment of HCV Infection(2011)1,534 cited
- → Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study(2014)814 cited
- → Human Immunodeficiency Virus Type 1 in the Semen of Men Receiving Highly Active Antiretroviral Therapy(1998)425 cited
- → Telaprevir Alone or With Peginterferon and Ribavirin Reduces HCV RNA in Patients With Chronic Genotype 2 but Not Genotype 3 Infections(2011)178 cited
- → Evolution of Treatment-Emergent Resistant Variants in Telaprevir Phase 3 Clinical Trials(2013)164 cited
- → Telaprevir Is Effective Given Every 8 or 12 Hours With Ribavirin and Peginterferon Alfa-2a or -2b to Patients With Chronic Hepatitis C(2010)147 cited
- → Quality of life in dermatology(2000)131 cited
- → Virology analyses of HCV isolates from genotype 1-infected patients treated with simeprevir plus peginterferon/ribavirin in Phase IIb/III studies(2014)131 cited
- → CD4 T Lymphocyte Count and the Radiographic Presentation of Pulmonary Tuberculosis(1995)101 cited
- → Combination treatments including the small-interfering RNA JNJ-3989 induce rapid and sometimes prolonged viral responses in patients with CHB(2022)100 cited